Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal Inflammation
A prospective study aims to identify predictive biomarkers that distinguish postoperative recurrence and complications in ulcerative colitis…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Ibd CAncer and seRious Infections in France (I-CARE 2)
This clinical trial update indicates ongoing recruitment for I-CARE 2 in France. The study examines cancer risk and serious infections in in…
-
FDA approval · 2025-03-13FDA Approved: USTEKINUMAB-TTWE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for USTEKINUMAB-TTWE from Quallent Pharmaceuticals Health LLC, updating the product’s labeling a…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Changes in Faecal Calprotectin Levels and Participation-related Scores Following Three Weeks of Inpatient Rehabilitation
A completed clinical trial assessing changes in Faecal Calprotectin levels and participation-related scores after three weeks of inpatient r…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Psychological Intervention for Fatigue in Inflammatory Bowel Diseases [NA]
A clinical trial is evaluating a psychological intervention to reduce fatigue in inflammatory bowel disease, including Crohn's disease and u…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-03-06FDA Approved: MESALAMINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Mesalamine submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease [Phase 2]
Amgen conducted a Phase 2 trial to evaluate the safety and activity of an oral medication for moderate-to-severe Crohn's disease; the study …
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease [Phase 2]
Phase 2 trial evaluating CCX282-B for moderate-to-severe Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Non-invasive Vagus Nerve Stimulation in the Treatment of Crohn's Disease - A Pilot Study [NA]
A pilot study evaluated non-invasive vagus nerve stimulation as a treatment for Crohn's disease. The trial was terminated and results were p…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.
An observational multicenter study sponsored by Meyer Children's Hospital IRCCS is recruiting to examine eating habits and their association…
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease [Phase 1, Phase 2]
Phase 1 and Phase 2 clinical trials are exploring fluorescence imaging with Risankizumab-800CW in inflammatory bowel disease, including ulce…
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium
A clinical trial update on the study assessing treatment patterns and outcomes with upadacitinib in adults with inflammatory bowel disease i…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease
The trial update reports the completed study evaluating the risk of drug exposure to infants breastfed by women with inflammatory bowel dise…
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: Safety and Efficacy of MBF-118 in Patients with Crohn Disease [Phase 2]
Phase 2 trial update showing safety and efficacy signals for MBF-118 in Crohn's disease.
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
Clinical trial update on high-dose, interval Vitamin D supplementation for patients with inflammatory bowel disease on biologic therapy; rec…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease [NA]
A recruiting clinical trial evaluating proactive infliximab monitoring and optimization in inflammatory bowel disease, including Crohn's dis…
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: Microbial Restoration in Inflammatory Bowel Diseases [Phase 1, Phase 2]
A clinical trial update describing Phase 1/2 studies evaluating microbial restoration using fecal microbiota transplantation for Crohn's dis…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Role of IL 12 and IL 23 as Potential Biomarkers in Diagnosis of Early Crohn's Disease
This completed clinical trial evaluated whether interleukin-12 and interleukin-23 could serve as biomarkers for diagnosing early Crohn's dis…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease [Phase 3]
Phase 3 study evaluating subcutaneous guselkumab for moderately to severely active Crohn's disease; results have been posted for this trial …
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease [Phase 3]
Phase 3 trial update for guselkumab subcutaneous therapy in moderately to severely active Crohn's disease; status active not recruiting with…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Reliability of IUS in Crohn's Disease [NA]
A clinical trial at Centre Hospitalier Universitaire d'Amiens is evaluating the reliability of intestinal ultrasound (IUS) in Crohn's diseas…
-
FDA approval · 2025-02-18FDA Approved: MESALAMINE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's original ANDA for Mesalamine, a generic mesalamine product. This approval authorizes marketing for ulcerative colitis,…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD) [NA]
This registry entry notes a recruiting study evaluating psychologist-administered and self-administered cognitive behavioral therapy for anx…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Effect of Anti-inflammatory Diet in Patients With Inflammatory Bowel Disease [NA]
A clinical trial is evaluating the effects of an anti-inflammatory diet in patients with inflammatory bowel diseases and is currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Special Physical Exercises as a Therapeutic Intervention for Inflammatory Bowel Disease [NA]
Clinical trial evaluating special physical exercises as a therapeutic intervention for inflammatory bowel disease has completed. The study e…